top of page

Australia-Based Cure Brain Cancer Foundation, Qatar Cancer Society, Initiate Discussion of Strategic

[SYDNEY] Cure Brain Cancer Foundation and Qatar Cancer Society are pleased to announce the start of discussions of a strategic collaborative partnership which will play a vital role in progressing cancer research, advancements, and treatments globally.

“Qatar is leading the way in philanthropic impact investing, in particular its support for biotechnology companies in cancer treatment,” said Lance Kawaguchi, Chief Executive Officer of Cure Brain Cancer Foundation. “With both organizations supporting research globally to fast-track more treatments in adult and pediatric cancers, our synergies are aligned and will benefit progress in crucial cancer research and treatment.”

This partnership has received support from respected and influential leaders around the world, including the esteemed Founder and Chairperson of Qatar Cancer Society, His Excellency, Sheikh Dr. Khalid Bin Jabor Al Thani.

Qatar Cancer Society is optimistic about what this future strategic collaborative partnership will bring.

“Lance has lifted a small, little known Australian-based charity into a major player in brain cancer globally in only two years,” said Sheikh Dr. Khalid. “His passion, vision, and relentless drive has powered Cure Brain Cancer Foundation to the world stage, and we at Qatar Cancer Society echo his vision and passion for a cancer free world.”

Qatar Cancer Society is the country’s primary non-profit organization promoting cancer awareness and prevention. Cure Brain Cancer Foundation’s future strategic collaborative partnership with it could significantly increase cancer research, new drug development, and clinical trial funding and capabilities.


About Cure Brain Cancer Foundation

Cure Brain Cancer Foundation is an Australia-based non-profit organization that is working globally to rapidly improve disease survival through funding innovative brain cancer research. It is the largest dedicated funder of brain cancer research in Australia and has invested over $30 million into clinical trials and pre-clinical efforts across pediatric and adult brain cancers. The Foundation’s mission is to unite the brain cancer community and rapidly increase patient survival and quality of life. For more information, visit

14 views0 comments
bottom of page